Clinical Trials Begin for mRNA Cancer Vaccine Targeting Lynch Syndrome
針對林奇症候群的 mRNA 癌症疫苗開始進行臨床試驗
Introduction
The University of Oxford and Moderna have created an mRNA vaccine to prevent cancer in people with Lynch syndrome. Clinical trials for this new treatment are scheduled to begin this summer.
牛津大學與 Moderna 研發了一款 mRNA 疫苗，用以預防林奇症候群患者罹患癌症。這項新療法的臨床試驗預計將於今年夏天開始。
Main Body
The Intercept-Lynch trial focuses on the mRNA-4194 vaccine, which is designed for people with a genetic condition that prevents their bodies from repairing DNA. This deficiency greatly increases the risk of developing colorectal, ovarian, and endometrial cancers. The vaccine works by using mRNA technology as a set of instructions, which allows the immune system to find and destroy pre-cancerous cells before they become malignant.
Intercept-Lynch 試驗聚焦於 mRNA-4194 疫苗，該疫苗是為患有基因缺陷而導致身體無法修復 DNA 的人群所設計。這種缺陷會大大增加罹患大腸癌、卵巢癌及子宮內膜癌的風險。疫苗利用 mRNA 技術作為一套指令，讓免疫系統在癌前細胞轉變為惡性之前，就能地發現並摧毀它們。
This project is Moderna's first time using mRNA technology specifically to prevent cancer, and it is supported by Cancer Research UK. The first phase of the study aims to find the correct dose, ensure the vaccine is safe, and analyze how the immune system responds. If these results are successful, a larger second phase involving multiple centers is expected to start in 2027.
此計畫是 Moderna 首次專門使用 mRNA 技術來預防癌症，並得到了英國癌症研究基金會 (Cancer Research UK) 的支持。研究的第一階段旨在確定正確劑量、確保疫苗安全性，並分析免疫系統的反應。若結果成功，預計將於 2027 年啟動涉及多個中心的更大規模第二階段試驗。
Researchers emphasize that the vaccine targets markers found in several different Lynch-related cancers, which could provide wide-ranging protection. Furthermore, the University of Oxford suggests that if this method works, it could be adapted to prevent other types of cancer that are not related to Lynch syndrome.
研究人員強調，該疫苗針對在數種不同林奇相關癌症中發現的標記，能提供廣泛的保護。此外，牛津大學建議，如果此方法有效，未來可將其調整以預防其他與林奇症候群無關的癌症類型。
Conclusion
The project is currently starting safety and effectiveness trials, with larger clinical tests planned for 2027.
該計畫目前正開始進行安全性與有效性試驗，更大規模的臨床測試計劃於 2027 年進行。
Vocabulary Learning
🚀 From 'Simple' to 'Sophisticated'
At the A2 level, you likely use basic verbs like help, do, or make. To reach B2, you need Precise Action Verbs. Look at how this text describes scientific processes. It doesn't just say "the vaccine helps"; it uses words that describe how it helps.
⚡ The Power Move: Precision Verbs
| A2 Style (Simple) | B2 Style (Precise) | Why it's better |
|---|---|---|
| help the body | prevent cancer | It specifies that the cancer won't start |
| fix DNA | repair DNA | 'Fix' is general; 'repair' is technical and professional |
| stop cells | destroy cells | It describes the complete elimination of the threat |
| change the method | adapt the method | It means changing something to fit a new purpose |
🛠️ Logic Connectors for Fluency
B2 speakers don't just list facts; they link ideas to show cause and effect. Notice the word "Furthermore" in the text.
Instead of saying: "The vaccine targets many cancers. Also, it can be used for other cancers."
A B2 speaker says: "The vaccine targets several cancers. Furthermore, it could be adapted for other types."
Pro Tip: Use Furthermore or Moreover when you want to add a stronger, more important point to your argument. It signals to the listener that you are building a complex case, not just making a list.
💡 Quick Shift: The 'Passive' Vibe
Check this phrase: "...is expected to start in 2027."
An A2 student says: "I think it will start in 2027."
A B2 student uses the passive-style structure (is expected to) to sound more objective and formal. Use this when you aren't 100% sure, but the general consensus or plan says it will happen.